{"organizations": [], "uuid": "c0a1a02cc7091efc4115c4bf51f7ac0101ca6f05", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.afr.com", "main_image": "http://www.afr.com/content/dam/images/g/h/h/p/d/6/image.related.afrArticleLead.620x365.ginimf.png/1438215985667.jpg", "site_section": "http://www.afr.com/", "section_title": "Financial Review - Business, Finance and Investment News | afr.com", "url": "http://www.afr.com/business/health/pharmaceuticals/novogen-to-review-its-preclinical-trials-20150730-ginimf", "country": "AU", "title": "Novogen to review its pre-clinical trials", "performance_score": 0, "site": "afr.com", "participants_count": 1, "title_full": "Novogen to review its pre-clinical trials | afr.com", "spam_score": 0.0, "site_type": "news", "published": "2015-07-30T08:26:00.000+03:00", "replies_count": 0, "uuid": "c0a1a02cc7091efc4115c4bf51f7ac0101ca6f05"}, "author": "afr.com", "url": "http://www.afr.com/business/health/pharmaceuticals/novogen-to-review-its-preclinical-trials-20150730-ginimf", "ord_in_thread": 0, "title": "Novogen to review its pre-clinical trials", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Novogen has launched a company-wide review. Novogen The acting chief executive of cancer researcher Novogen has launched a company-wide review that could impact some of its projects.\nIain Ross was last week appointed to run the company after former chief executive and founder Graham Kelly resigned to pursue his own research.\nMr Ross on Thursday said Novogen will immediately review its pre-clinical programs in detail.\n\"Whilst not wanting to pre-empt the outcome of the review I anticipate we may have to re-prioritise some of the programs,\" he said.\nNovogen has two cancer drugs in development that it aims to progress to clinical trials in 2016, and a third that could be progress to human trials in 2016/17.\nAAP dmc/bt\n ", "external_links": [], "published": "2015-07-30T08:26:00.000+03:00", "crawled": "2015-07-30T04:42:48.355+03:00", "highlightTitle": ""}